Rheumatoid arthritis

Current diagnostic pathways for rheumatoid arthritis-associated interstitial lung disease result in substantial underdiagnosis and excess mortality: A multicenter Norwegian quality assurance audit

Joint Bone SpinePublished Multicentre quality assurance audit

Authors' conclusion

When comparing to prevalence expectations, current routine care may leave a substantial proportion of cases undetected, primarily capturing a high-risk phenotype with excess mortality.

Study context

Population
RA patients at six Norwegian centers covering 43% of the Norwegian population
Participants
17,305 RA patients
Comparison
RA-ILD vs 3:1 frequency-matched RA controls (mortality); detected prevalence vs 10% expected target
  • RA-ILDn = 188
Outcome
Prevalence of currently detected RA-ILD, benchmarked against a 10% expected target
Methodological details10-year, six centers, ICD-10 case identification confirmed by manual chart review, 3:1 frequency-matched RA controls, Cox proportional hazards regression
  • 10-year
  • Six centers
  • ICD-10 case identification confirmed by manual chart review
  • 3:1 frequency-matched RA controls
  • Cox proportional hazards regression

Main finding

As reported in the abstract

Verified ILD prevalence among RA patients

RA-ILD

1.1%

188

Diagnostic gap vs expected 10% prevalence
89%

Further findings

OutcomeRA-ILDRA controlsHR (95% CI)P value
Mortality4.1/100 person-years2.3/100 person-years1.77 (1.31–2.39)P < 0.001

Characteristics of RA-ILD cases

Mean age at ILD detection (years)
67.5
≥2 established risk factors
93.6%
Seropositive
93.6%
Smoking history
76.1%
RA onset age≥60 and persistently increased inflammatory markers
over half

Original publication

Current diagnostic pathways for rheumatoid arthritis-associated interstitial lung disease result in substantial underdiagnosis and excess mortality: A multicenter Norwegian quality assurance audit. Joint Bone Spine. Published 1 September 2026. doi:10.1016/j.jbspin.2026.106130

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.